|
|
|
Volumn 27, Issue 12, 1999, Pages 858-860
|
|
Effects of raloxifene on bone loss and fracture risk in postmenopausal woman;Effets du raloxifene sur la perte osseuse et le risque fracturaire chez la femme menopausee
a
|
|
Author keywords
Osteoporosis; Prevention; Raloxifene; Treatment
|
|
Indexed keywords
CENTCHROMAN;
DROLOXIFENE;
ESTROGEN RECEPTOR;
IDOXIFENE;
LOW DENSITY LIPOPROTEIN;
RALOXIFENE;
LIPID;
PLACEBO;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
ADULT;
ARTICLE;
BONE ATROPHY;
BONE DENSITY;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MECHANISM;
ESTROGEN THERAPY;
FEMALE;
FRACTURE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LIPID BLOOD LEVEL;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
POSTMENOPAUSE OSTEOPOROSIS;
THROMBOEMBOLISM;
VERTEBRA FRACTURE;
AGED;
BLOOD;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
MENOPAUSE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
SPINE FRACTURE;
AGED;
BONE DENSITY;
FEMALE;
HUMANS;
LIPIDS;
MENOPAUSE;
MIDDLE AGED;
OSTEOPOROSIS, POSTMENOPAUSAL;
PLACEBOS;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
SPINAL FRACTURES;
|
|
EID: 0033255146
PISSN: 11651083
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (9)
|
